Clinical Cancer Research Targets Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.
Right arrow Articles by Li, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.
Right arrow Articles by Li, C.-Y.
Clinical Cancer Research Vol. 9, 1155-1160, March 2003
© 2003 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Increased Resistance of Tumor Cells to Hyperthermia Mediated By Integrin-linked Kinase1

Xiuwu Zhang, Yongping Li, Qian Huang, He Wang, Bin Yan, Mark W. Dewhirst and Chuan-Yuan Li2

Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710 [X. Z., Y. L., H. W., B. Y., M. W. D., C-Y. L.], and No. 1 People’s Hospital, Shanghai, China [Q. H.]

Purpose: Integrin-linked kinase (ILK) is a serine-threonine kinase associated with anchorage-independent growth and tumorigenic transformation. Previous studies indicate that overexpression of ILK is common among several types of tumors, and it is involved in the regulation of tumor cell survival under stress. In this study, we examined the effects of ILK expression on tumor cellular response to hyperthermia.

Experimental Design: We used an adenovirus-mediated approach to overexpress the ILK gene in a prostate cancer cell line and examine its effects on heat stress-induced cell death. Clonogenic survival, as well as apoptosis, was evaluated in cells that overexpress ILK. In addition, the ability to form tumors in vivo was examined in syngeneic hosts. Finally, potential molecular mechanisms of ILK-mediated resistance to heat were examined by determining the status of a variety of signal transduction pathways.

Results: ILK overexpression made tumor cells significantly more resistant to the cell-killing effects of hyperthermia. This was correlated at the molecular level with the down-regulation of hyperthermia-induced activation of stress-activated protein kinase/c-Jun-NH2-terminal kinase, p38 mitogen-activated protein kinase activities, and caspase 9. The overexpression of ILK was also shown to induce a more rapid tumor growth in a murine prostate cancer cell line

Conclusion: ILK plays an important role in tumor growth and tumor response to hyperthermia treatment.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Ohnishi, G. Hasegawa, M. Yamasaki, H. Obayashi, M. Fukui, T. Nakajima, Y. Ichida, H. Ohse, S.-i. Mogami, T. Yoshikawa, et al.
Integrin-linked kinase acts as a pro-survival factor against high glucose-associated osmotic stress in human mesangial cells
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1786 - 1793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Nho, H. Xia, J. Kahm, J. Kleidon, D. Diebold, and C. A. Henke
Role of Integrin-linked Kinase in Regulating Phosphorylation of Akt and Fibroblast Survival in Type I Collagen Matrices through a {beta}1 Integrin Viability Signaling Pathway
J. Biol. Chem., July 15, 2005; 280(28): 26630 - 26639.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zhang, T. Kon, H. Wang, F. Li, Q. Huang, Z. N. Rabbani, J. P. Kirkpatrick, Z. Vujaskovic, M. W. Dewhirst, and C.-Y. Li
Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1{alpha}
Cancer Res., November 15, 2004; 64(22): 8139 - 8142.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.